Yes. GENinCode was formerly owned by 2 private investors.
GENinCode is headquartered in Manchester, United Kingdom.
GENinCode disclosed revenue of 3M GBP for 2024 and 2M GBP for 2023.
GENinCode has 42 employees.
GENinCode is a life science company.
GENinCode was founded in 2018.
One St. Peters Square,
Manchester,
M2 3DE
United Kingdom,
+44 (0)1865 676 125
www.genincode.com
GENinCode provides advanced genomic technology, products and recommendations fully validated by company's scientific and clinical team. GENinCode goal is to provide doctors and health care practitioners with advanced health information that combines both traditional clinical measures with a patient’s genetic information to provide a comprehensive risk assessment and clinical recommendation to help decision-making. GENinCode was founded in 2018 and is based in Oxford, United Kingdom.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | - | 1 | - | - | - | 1 |
| vol | $1M | $1M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
